Castle Biosciences, Inc. (CSTL)
33.08
-0.11
(-0.33%)
USD |
NASDAQ |
Oct 23, 16:00
33.18
+0.10
(+0.30%)
After-Hours: 20:00
Castle Biosciences Enterprise Value : 779.07M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 779.07M |
| October 22, 2026 | 782.42M |
| October 21, 2026 | 818.42M |
| October 20, 2026 | 781.20M |
| October 19, 2026 | 751.15M |
| October 16, 2026 | 744.90M |
| October 15, 2026 | 801.03M |
| October 14, 2026 | 779.98M |
| October 13, 2026 | 772.96M |
| October 12, 2026 | 769.30M |
| October 09, 2026 | 819.95M |
| October 08, 2026 | 798.29M |
| October 07, 2026 | 776.63M |
| October 06, 2026 | 787.61M |
| October 05, 2026 | 887.98M |
| October 02, 2026 | 854.73M |
| October 01, 2026 | 845.42M |
| September 30, 2026 | 853.81M |
| September 29, 2026 | 833.98M |
| September 28, 2026 | 866.02M |
| September 25, 2026 | 862.35M |
| September 24, 2026 | 843.44M |
| September 23, 2026 | 833.98M |
| September 22, 2026 | 833.07M |
| September 21, 2026 | 837.34M |
| Date | Value |
|---|---|
| September 18, 2026 | 848.02M |
| September 17, 2026 | 891.95M |
| September 16, 2026 | 852.29M |
| September 15, 2026 | 852.90M |
| September 14, 2026 | 790.05M |
| September 11, 2026 | 756.18M |
| September 10, 2026 | 755.88M |
| September 09, 2026 | 755.57M |
| September 08, 2026 | 769.30M |
| September 04, 2026 | 773.88M |
| September 03, 2026 | 765.95M |
| September 02, 2026 | 789.44M |
| September 01, 2026 | 790.05M |
| August 31, 2026 | 777.54M |
| August 28, 2026 | 791.88M |
| August 27, 2026 | 815.07M |
| August 26, 2026 | 809.57M |
| August 25, 2026 | 837.64M |
| August 24, 2026 | 790.96M |
| August 21, 2026 | 813.24M |
| August 20, 2026 | 774.49M |
| August 19, 2026 | 755.88M |
| August 18, 2026 | 655.51M |
| August 17, 2026 | 683.57M |
| August 14, 2026 | 673.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| RadNet, Inc. | 7.288B |
| Lumexa Imaging Holdings, Inc. | 2.026B |
| Quest Diagnostics, Inc. | 32.49B |
| Labcorp Holdings, Inc. | 33.25B |
| OPKO Health, Inc. | 1.313B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.06M |
| Revenue (Quarterly) | 103.55M |
| Total Expenses (Quarterly) | 105.61M |
| EPS Diluted (Quarterly) | -0.0678 |
| Gross Profit Margin (Quarterly) | 74.29% |
| Profit Margin (Quarterly) | -1.99% |
| Earnings Yield | -1.97% |
| Normalized Earnings Yield | -2.156 |